Literature DB >> 2613845

Automated gas chromatographic-electron-capture assay for the selective serotonin uptake blocker sertraline.

L M Tremaine1, E A Joerg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613845     DOI: 10.1016/s0378-4347(00)82590-6

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  10 in total

1.  Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N-demethylation of sertraline in human liver microsomes.

Authors:  Z H Xu; W Wang; X J Zhao; S L Huang; B Zhu; N He; Y Shu; Z Q Liu; H H Zhou
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

Review 2.  Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  C L DeVane
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

Review 3.  Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Authors:  P Baumann
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

4.  Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.

Authors:  R A Ronfeld; L M Tremaine; K D Wilner
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

5.  Sertraline. Chronopharmacokinetics and the effect of coadministration with food.

Authors:  R A Ronfeld; K D Wilner; B A Baris
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

6.  Effect of sertraline on the pharmacokinetics and protein binding of diazepam in healthy volunteers.

Authors:  M J Gardner; B A Baris; K D Wilner; S H Preskorn
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

7.  Effect of sertraline on protein binding of warfarin.

Authors:  G Apseloff; K D Wilner; N Gerber; L M Tremaine
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

8.  A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide.

Authors:  L M Tremaine; K D Wilner; S H Preskorn
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

Review 9.  Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.

Authors:  D Murdoch; D McTavish
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

10.  Development and validation of stability indicating method for determination of sertraline following ICH guidlines and its determination in pharmaceuticals and biological fluids.

Authors:  Mohamed I Walash; Fathallah F Belal; Nahed M El-Enany; Heba Elmansi
Journal:  Chem Cent J       Date:  2011-10-13       Impact factor: 4.215

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.